Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)

Giuseppe Fallara1, Alessandro Larcher1, Saeed Dabestani2

  • 1Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy.

Urologic Oncology
|September 20, 2022
PubMed
Summary

Minimally invasive surgery for localized renal cell carcinoma (RCC) increases the risk of local recurrence and uncommon metastases compared to open surgery. However, survival outcomes including disease-free survival (DFS), overall survival (OS), and cancer-specific survival (CSS) remain comparable between the two approaches.